CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Older Black men account for a growing share of Milwaukee drug deaths as fentanyl creeps into cocaine supplies, catching a ...

Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

One of the biggest names in adult entertainment had been left 'permanently disabled' after seeking treatment for a serious ...

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...